Breaking AI & Tech News Analyzed

Bangladesh’s Ministry of Health and Family Welfare disclosed that a suspected measles outbreak has killed at least 98 children in the past three weeks, prompting an urgent escalation of vaccination efforts in Dhaka’s hardest‑hit districts.Prime Minister Tarique Rahman ordered two senior ministers to tour the nation’s 170 million residents, assess the crisis’s scale, and coordinate a rapid response.Official data released on Sunday show that 6,476 children aged six months to five years exhibited measles‑like symptoms, while 826 cases have been laboratory‑confirmed with 16 confirmed deaths. Health officials note that many cases go untested, meaning the true toll could be higher.According to Halimur Rashid, director of Communicable Disease Control, “Compared with past years, the number of affected children is higher, and the death toll is higher too.” He attributes the surge to multifactorial causes, including a shortage of vaccines.World Health Organization (WHO) records indicate the highest number of suspected measles cases in Bangladesh was 25,934 in 2005. After a long decline, this year’s figures represent a stark reversal.Measles remains one of the world’s most contagious diseases, spreading through coughs and sneezes. While it can affect any age group, children under five are most vulnerable to severe complications such as brain swelling and respiratory failure. WHO estimates up to 95,000 measles deaths globally each year, primarily among unvaccinated or under‑vaccinated children.Bangladesh has previously achieved notable progress in immunisation, yet a scheduled measles‑vaccination drive for June 2024 was postponed after a violent uprising that ousted Prime Minister Sheikh Hasina. Consequently, many children—some as young as six months—missed the routine nine‑month vaccine dose.Mahmudur Rahman, chief of the National Verification Committee of Measles and Rubella, acknowledged the missed target of eliminating measles deaths by December 2025, citing “poor vaccination programmes.”In response, Dhaka has identified 30 districts with the highest case numbers and launched an emergency vaccination campaign. Health Minister Sardar Shakhawat Hossain Bakul pledged that the drive will first cover the “worst affected areas” before expanding nationwide.Public‑health expert Tajul Islam A Bari, a former official of the Expanded Programme on Immunisation, warned that although funds were allocated for vaccine procurement, the government failed to secure the doses, leading to the current “scary” situation.With no specific treatment for measles once contracted, the focus remains on accelerating vaccine delivery, improving surveillance, and preventing further loss of young lives.

Disturbing footage has emerged showing an Israeli military dog attacking a Palestinian man inside a mosque. The incident has sparked widespread concern and outrage over human rights violations and the conduct of Israeli military forces.The video, obtained from Al Jazeera, provides a harrowing glimpse into the incident, which has not been officially commented on by Israeli authorities. The lack of transparency and accountability in such cases often exacerbates tensions between Israel and Palestine.Human rights organizations have repeatedly criticized the Israeli military for its treatment of Palestinian civilians, citing numerous instances of excessive force and abuse. This latest incident is likely to fuel ongoing debates about military conduct and the need for greater oversight.

Cambodia has taken a significant step in its fight against cybercrime by approving a new law targeting scam centers accused of defrauding foreigners of billions of dollars. The law, which aims to enhance the country's 'cleaning operation' against these illicit operations, imposes punishments of two to five years in prison and fines of up to $125,000 for those convicted of online scams.The legislation, which will now go to Cambodia's king for a final signature, also outlines penalties for money laundering, gathering victims' data, or recruiting scammers. Ringleaders of scam centers that engage in human trafficking, detentions, and torture will face prison sentences of up to 20 years and fines of up to $500,000.The passage of the law comes amid widespread condemnation from rights groups and sanctions by governments around the world, with Cambodia accused of being a hotbed of cyberscams. The US Department of State has previously stated that 'official complicity, including at senior levels, inhibited effective law enforcement action against trafficking crimes' in Cambodia, which has denied these allegations.The new law is seen as a significant effort by Cambodia to combat the rise of online fraud, romance, and cryptocurrency scams. Several countries have enacted anti-cyberscam laws to address this issue, with con artists in Singapore facing 24 strokes of the cane in serious cases.Justice Minister Keut Rith emphasized that the law is 'strict like the fishing net' and aims to ensure that online scams do not return to Cambodia. The law is expected to send a strong message to cyberscammers that Cambodia is not a place to conduct scams, and it will serve the interests of the Cambodian nation and people.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The United States has long honored past presidents by naming airports, dams and monuments after them, but President Donald Trump is pushing the practice to an extreme, seeking to become the most commemorated leader in American history. Less than a year and a half into his second term, Trump’s brand has proliferated across government buildings, federal agencies and even consumer platforms. In February, the administration unveiled TrumpRx, a prescription‑drug website that listed only 43 medications—most of which are available as cheaper generics elsewhere—yet proudly displayed the former president’s signature and logo. Just weeks later, the White House and the U.S. Navy announced a new "Trump class" of battleships, billed as the "largest ever built." A Pentagon release noted that the Navy has not used battleships in combat for 35 years, suggesting the project is more a vanity exercise than a strategic necessity. Federal institutions have not been spared. In December 2025 the U.S. Institute of Peace was renamed the "Donald J. Trump United States Institute of Peace," a move the White House framed as a reminder of "strong leadership" for global stability—just weeks before the administration launched a military strike on Iran. Trump’s influence extended to the arts when, in February 2025, he appointed a new board to the John F. Kennedy Center for the Performing Arts and installed himself as chair. The board voted in December to rename the venue the "Donald J. Trump and John F. Kennedy Center," a change that immediately faced a legal challenge. Republican lawmakers have largely embraced the naming spree. One congressman introduced legislation to carve Trump’s likeness onto Mount Rushmore, while another proposed naming a major airport after him, underscoring the party’s willingness to reward the president’s personal brand. Political scientist Steven Levitsky of Harvard warned that Trump operates "unconstrained" by advisers or party elders, noting that today’s Republican ambition often hinges on pleasing the president, including attaching his name to public projects. Visual propaganda has also surged. Giant banners bearing Trump’s image now hang from the Department of Justice and the Department of Labor buildings, a rarity for a sitting president and a practice more typical of authoritarian regimes, according to Princeton sociologist Kim L. Scheppele. Beyond buildings, the administration has pursued numismatic honors. A 24‑karat gold coin featuring Trump standing over a desk was approved by a hand‑picked arts commission, and drafts of a new $1 coin displayed an air‑brushed profile of the former president. The Treasury Department announced that Trump’s signature will appear on U.S. paper currency later this year, a move Treasury Secretary Scott Bessent described as a "powerful way to recognize historic achievements" of the nation. Critics argue that the public does not share the president’s enthusiasm. The 2026 National Parks Pass, which traditionally showcases natural scenery, sparked outrage when a draft featured Trump’s stern face with a spectral George Washington behind him. A cottage industry of stickers emerged to cover the image, forcing the National Park Service to warn that such alterations could void the pass. White House spokesperson Davis Ingle defended the branding, claiming it reflects Trump’s “vast accomplishments,” including the largest tax cut in history and border security measures. Yet scholars and opponents contend that the relentless self‑promotion blurs the line between public service and personal aggrandizement. As the branding campaign continues, legal challenges, public pushback, and questions about fiscal priorities suggest that Trump’s quest to name everything after himself may soon encounter more than just decorative resistance.

At the Oxford Brookes Headington campus, a group of over 100 students are working tirelessly to build the fastest and best-designed race car possible for this year’s Formula Student competition.The Oxford Brookes Racing (OBR) team, the UK’s most prestigious Formula Student team, has won more design awards than any other UK university and frequently secures top spots in the international race held annually at Silverstone.Success in the competition is crucial as it gets the team noticed by the industry, where a handful of engineering jobs can have upwards of 10,000 applicants. Several OBR alumni are currently working in every Formula One team.“A lot of the coverage on TV is based around the drivers, but not really the actual engineers,” said Thomas Cawdery, a team manager and third-year motorsports technology student. “This is what you don’t see in Formula One. The engineers who make it happen.”The OBR team is entirely run by students and operates out of two buildings, where scores of people are working hard – cutting and shaping carbon fibre chassis by hand, and running simulations on computers. Students of all ages are teaching and learning from one another.While actual Formula One cars have much more power than the students are allowed for safety reasons, the complexity of the cars is very similar. “They’re the same if not more complex than Formula One cars,” Cawdery said.The OBR team surpasses industry expectations in some aspects, particularly in terms of gender balance. Unlike most Formula One teams, where only about 10% of engineers are women, OBR has a much better gender balance.Emma Deery, a first-year mechanical engineering student, finds the inclusive environment encouraging. “In the industry, a lot of women find themselves the only woman on their team. Here it’s different. We have a lot more women and a lot of women in leadership roles.”The OBR team will compete for the top spot this summer against 102 other teams from 27 countries. The competition is a useful recruitment tool for big industry names, as it showcases innovative engineering skills.Ross Brawn, the legendary former team principal, once said, “There are two really innovative forms of motorsport left. One of them is Formula One and the other one is Formula Student.”

Peter Whelan and the Irish Baroque Orchestra have returned Handel’s Messiah to Dublin, the city of its 1742 debut, with a landmark recording that is the first period‑instrument rendition by an Irish ensemble. The project seeks to echo the original performance at the Fishamble Street music hall, where audience etiquette was so strict that women were asked to forgo hoop skirts and men to leave their swords at home.The album features a cast of historically informed singers. Helen Charlston delivers the contralto arias once associated with the scandal‑ridden Susannah Cibber, her voice described as firm, slightly metallic and unflaggingly expressive. A rare duet‑and‑chorus version of “How Beautiful Are the Feet,” originally written for two Dublin cathedral countertenors, showcases Alexander Chance in buoyant form, while soprano Hilary Cronin provides a sweet‑sounding contrast.Whelan draws a fleet‑footed performance from a modest 13‑member choir and the orchestra, resulting in vocal lines that are light, precise, and at times almost conversational. Formerly a bassoonist with the orchestra, Whelan is poised to succeed Nicholas McGegan as music director of San Francisco’s Philharmonia Baroque, cementing his status as a rising star in the baroque world.Listeners can stream the recording on Apple Music or Spotify.

The BBC Philharmonic, under the baton of John Storgårds, has released an album featuring Dmitri Shostakovich's Symphonies No 2 and 5. This pairing brings together one of the composer's most familiar works with one of his lesser-known pieces.The Symphony No 2, commissioned as propaganda for the 10th anniversary of the October Revolution, is an early experiment by the 21-year-old Shostakovich. It begins with eerie, foggy strings that slide up and down in an intangible, almost pitchless way, more akin to a sound effect than music. As it builds, the symphony becomes a perpetual motion melee, culminating in a celebratory chorus singing 'October, the Commune and Lenin'.In contrast, the Symphony No 5, written a decade later, showcases a more mature composer. Storgårds' interpretation doesn't quite capture the depth of darkness in the first movement, but his warmth in the harmonies brings the music to life. The third movement has a compelling stillness, while the finale expertly increases tension through small tempo changes.This album review highlights the stark contrast between Shostakovich's early experimentation and his later mastery. The performance by the BBC Philharmonic and John Storgårds is effective, making this album a valuable addition to any classical music collection.

The latest Supergirl trailer has generated significant buzz, hinting at a fresh take on the iconic DC character. Director Craig Gillespie has revealed that the film will feature a nine-world structure and a considerable amount of planet-hopping, setting it apart from previous superhero films.Building on the success of James Gunn's Superman, which offered a unique twist on the Man of Steel, Milly Alcock's Kara Zor-El is poised to bring a new level of excitement to the DC Universe. The trailer showcases Alcock's character navigating alien landscapes and battling foes with a swagger reminiscent of a cosmic gunslinger.What sets this film apart is its exploration of Kara's vulnerabilities when she's away from Earth's yellow sun. In the comic book series Supergirl: Woman of Tomorrow, Kara encounters a world under a green sun that drains her powers, making her physically ill. This element could add a layer of complexity to the story, as Kara searches for an antidote across multiple planets.The film's setup has a video-game-like quality, with Kara's power levels potentially fluctuating as she navigates different environments. This mechanic could sharpen the drama and create a sense of tension, as Kara faces challenges that test her abilities.While there are risks involved in this bold new direction, the prospect of seeing a more vulnerable and dynamic Supergirl on the big screen is an intriguing one. As the DC Universe continues to evolve, fans are eager to see how this new take on a classic character will unfold.